Loading clinical trials...
Loading clinical trials...
Pilot Study to Assess the Efficacy of Aspirin to Improve Immunological Features of Ovarian Tumors
Conditions
Interventions
Aspirin 325mg
Placebo
Locations
4
United States
Moffitt Cancer Center
Tampa, Florida, United States
Oregon Health and Science University
Portland, Oregon, United States
University of Virginia Comprehensive Cancer Center
Charlottesville, Virginia, United States
Inova Schar Cancer Institute
Fairfax, Virginia, United States
Start Date
November 2, 2021
Primary Completion Date
July 1, 2026
Completion Date
December 1, 2026
Last Updated
April 1, 2026
NCT06257264
NCT06964009
NCT06547840
NCT07498829
NCT06503146
NCT05039801
Lead Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions